Menu
GeneBe

rs61731376

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2

The NM_004380.3(CREBBP):c.3128C>T(p.Ser1043Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00184 in 1,614,122 control chromosomes in the GnomAD database, including 39 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. S1043S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.010 ( 23 hom., cov: 32)
Exomes 𝑓: 0.00099 ( 16 hom. )

Consequence

CREBBP
NM_004380.3 missense

Scores

3
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5O:1

Conservation

PhyloP100: 1.07
Variant links:
Genes affected
CREBBP (HGNC:2348): (CREB binding protein) This gene is ubiquitously expressed and is involved in the transcriptional coactivation of many different transcription factors. First isolated as a nuclear protein that binds to cAMP-response element binding protein (CREB), this gene is now known to play critical roles in embryonic development, growth control, and homeostasis by coupling chromatin remodeling to transcription factor recognition. The protein encoded by this gene has intrinsic histone acetyltransferase activity and also acts as a scaffold to stabilize additional protein interactions with the transcription complex. This protein acetylates both histone and non-histone proteins. This protein shares regions of very high sequence similarity with protein p300 in its bromodomain, cysteine-histidine-rich regions, and histone acetyltransferase domain. Mutations in this gene cause Rubinstein-Taybi syndrome (RTS). Chromosomal translocations involving this gene have been associated with acute myeloid leukemia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

PP2
Missense variant where missense usually causes diseases, CREBBP
BP4
Computational evidence support a benign effect (MetaRNN=0.00389117).
BP6
Variant 16-3767842-G-A is Benign according to our data. Variant chr16-3767842-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 95042.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00996 (1516/152240) while in subpopulation AFR AF= 0.0338 (1404/41544). AF 95% confidence interval is 0.0323. There are 23 homozygotes in gnomad4. There are 698 alleles in male gnomad4 subpopulation. This position pass quality control queck.
BS2
High AC in GnomAd at 1517 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CREBBPNM_004380.3 linkuse as main transcriptc.3128C>T p.Ser1043Leu missense_variant 16/31 ENST00000262367.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CREBBPENST00000262367.10 linkuse as main transcriptc.3128C>T p.Ser1043Leu missense_variant 16/311 NM_004380.3 P1Q92793-1
CREBBPENST00000382070.7 linkuse as main transcriptc.3014C>T p.Ser1005Leu missense_variant 15/301 Q92793-2
CREBBPENST00000570939.2 linkuse as main transcriptc.1733C>T p.Ser578Leu missense_variant 11/235
CREBBPENST00000573672.1 linkuse as main transcriptn.382C>T non_coding_transcript_exon_variant 3/32

Frequencies

GnomAD3 genomes
AF:
0.00997
AC:
1517
AN:
152122
Hom.:
23
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0339
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00590
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00955
GnomAD3 exomes
AF:
0.00267
AC:
671
AN:
251464
Hom.:
10
AF XY:
0.00199
AC XY:
271
AN XY:
135896
show subpopulations
Gnomad AFR exome
AF:
0.0355
Gnomad AMR exome
AF:
0.00220
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000615
Gnomad OTH exome
AF:
0.00179
GnomAD4 exome
AF:
0.000993
AC:
1451
AN:
1461882
Hom.:
16
Cov.:
31
AF XY:
0.000825
AC XY:
600
AN XY:
727244
show subpopulations
Gnomad4 AFR exome
AF:
0.0340
Gnomad4 AMR exome
AF:
0.00295
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000232
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000378
Gnomad4 OTH exome
AF:
0.00214
GnomAD4 genome
AF:
0.00996
AC:
1516
AN:
152240
Hom.:
23
Cov.:
32
AF XY:
0.00938
AC XY:
698
AN XY:
74438
show subpopulations
Gnomad4 AFR
AF:
0.0338
Gnomad4 AMR
AF:
0.00589
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.00945
Alfa
AF:
0.00161
Hom.:
11
Bravo
AF:
0.0121
ESP6500AA
AF:
0.0335
AC:
147
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00312
AC:
379
Asia WGS
AF:
0.00260
AC:
9
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000119

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1Other:1
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Mar 18, 2013- -
not provided, no classification providedreference populationITMISep 19, 2013- -
Rubinstein-Taybi syndrome due to CREBBP mutations;C5193034:Menke-Hennekam syndrome 1 Benign:1
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsApr 21, 2022- -
Rubinstein-Taybi syndrome Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsApr 18, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxAug 21, 2018- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.32
Cadd
Benign
22
Dann
Uncertain
0.98
DEOGEN2
Uncertain
0.54
D;.;.
Eigen
Benign
-0.32
Eigen_PC
Benign
-0.14
FATHMM_MKL
Benign
0.72
D
LIST_S2
Uncertain
0.93
D;D;D
MetaRNN
Benign
0.0039
T;T;T
MetaSVM
Benign
-0.71
T
MutationAssessor
Benign
1.4
L;.;.
MutationTaster
Benign
0.92
D;D
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-1.8
N;N;.
REVEL
Benign
0.19
Sift
Benign
0.30
T;T;.
Sift4G
Benign
0.35
T;T;.
Polyphen
0.010
B;.;.
Vest4
0.17
MVP
0.70
MPC
0.049
ClinPred
0.020
T
GERP RS
4.6
Varity_R
0.085
gMVP
0.094

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61731376; hg19: chr16-3817843; API